HIV/STD Prevention Program for African American Males

非裔美国男性艾滋病毒/性病预防计划

基本信息

项目摘要

DESCRIPTION (provided by the applicant): Common use of condoms by young adults across all racial/ethic groups remains a formidable public health challenge, especially for African American males (Kennedy et al., 2007a,b,c; Kennedy et al., under review). As a call to action, a collaborative team of researchers proposes to conduct a four-year behavioral-driven research study to modify, implement and evaluate the efficacy of a promising brief condom promotion program in a two-arm randomized trial among African American males 18-24 years from 12 community centers on Chicago's South Side. Accordingly, we propose the following specific aims and related set of research questions: 1. Modify, implement, and assess the efficacy of a condom promotion program for African American males. 1.1. Will participants randomly assigned to the intervention report a statistically significant increase in the frequency of condom use and decrease in unprotected sexual intercourse (primary outcomes) relative to those assigned to the comparison group? 1.2. Will the intervention produce statistically significant positive effects on secondary outcomes (e.g., condom use self-efficacy, condom use decisional balance, etc.) relative to the comparison group? 1.3. Will the secondary outcomes mediate the relationship between intervention status and condom use (the primary outcome)? 2. Assess characteristics of program implementation and its relationship to changes in behavioral outcomes. 2.1. What was the level of implementation fidelity? 2.2. How is variation in implementation fidelity related to change in primary outcomes? For a nine-month formative phase, we will conduct a series of qualitative interviews with key informants and the target population to modify our existing program. Over the next 16 months, we will recruit 520 study participants from our recruitment sites to implement the intervention and comparison programs and assess the efficacy of the intervention program on a series of primary and secondary outcomes. Assuming 30% attrition rate (n=156), we expect to collect complete outcome data via Audio Computer Assisted Self Interview (ACASI) from about 364 participants over 12-months. In addition, we will conduct biological assessment of STDs to validate participants' self-reports on sexual behaviors at all assessment points. This proposed study is an extension of a recently completed NIH-funded R21 (PI: Kennedy) to develop, implement, and pilot a brief condom promotion program for African American males (Kennedy et al., 2007a,b,c; Kennedy et al., under review). We have assembled a collaborative team of experienced investigators and research partners to successfully implement this proposed project.
描述(由申请人提供):所有种族/族裔群体的年轻人普遍使用避孕套仍然是一个巨大的公共卫生挑战,特别是对非洲裔美国男性(Kennedy等人,2007年a,b,c; Kennedy等人,正在审查中)。作为一项行动呼吁,一个合作研究小组提议进行一项为期四年的行为驱动研究,以修改、实施和评估一项有前景的简短安全套推广计划的效果。该计划在芝加哥南区12个社区中心的18-24岁非裔美国男性中进行了一项两组随机试验。据此,我们提出以下具体目标和相关的一套研究问题:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen B. Kennedy其他文献

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries Query ID="Q1" Text="No Query"
  • DOI:
    10.1186/s13063-021-05572-3
  • 发表时间:
    2021-09-01
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Moses Badio;Edouard Lhomme;Mark Kieh;Abdoul Habib Beavogui;Stephen B. Kennedy;Seydou Doumbia;Bailah Leigh;Samba O. Sow;Alpha Diallo;Daniela Fusco;Matthew Kirchoff;Monique Termote;Renaud Vatrinet;Deborah Wentworth;Helène Esperou;H. Clifford Lane;Jerome Pierson;Deborah Watson-Jones;Céline Roy;Eric D’Ortenzio;Brian Greenwood;Genevieve Chêne;Laura Richer;James D. Neaton;Yazdan Yazdanpanah
  • 通讯作者:
    Yazdan Yazdanpanah
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A <em>post hoc</em> analysis of three Phase 2/3 trials
  • DOI:
    10.1016/j.vaccine.2022.09.037
  • 发表时间:
    2022-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jakub K. Simon;Stephen B. Kennedy;Barbara E. Mahon;Sheri A. Dubey;Rebecca J. Grant-Klein;Ken Liu;Jonathan Hartzel;Beth-Ann G. Coller;Carolee Welebob;Mary E. Hanson;Rebecca F. Grais
  • 通讯作者:
    Rebecca F. Grais
PP-193 Recruitment & retention strategies of high risk urban youth in an HIV/STD randomized controlled trial (RCT) in post-conflict Liberia
  • DOI:
    10.1016/s1201-9712(09)60587-7
  • 发表时间:
    2009-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Moses Kolubah;Stephen B. Kennedy;Mawen Gobeh;Monica Quaqua;Daisajou Woods;Matthew Warlonfa;Momolu Massaquoi
  • 通讯作者:
    Momolu Massaquoi
PP-157 Risky sexual behaviors among young urban females in post-conflict Liberia
  • DOI:
    10.1016/s1201-9712(09)60551-8
  • 发表时间:
    2009-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Oretha Perry;Stephen B. Kennedy;Ernree M. Bee;Pearl W. Fahnbulleh;Salome Garber;Ernlee M. Barbu;Wede M. Nagbe
  • 通讯作者:
    Wede M. Nagbe

Stephen B. Kennedy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen B. Kennedy', 18)}}的其他基金

HIV/STD Prevention Program for African American Males
非裔美国男性艾滋病毒/性病预防计划
  • 批准号:
    7810809
  • 财政年份:
    2010
  • 资助金额:
    $ 37.66万
  • 项目类别:
HIV/STD Prevention Program for African American Males
非裔美国男性艾滋病毒/性病预防计划
  • 批准号:
    8034291
  • 财政年份:
    2010
  • 资助金额:
    $ 37.66万
  • 项目类别:
HIV/STD Prevention Program for African American Males
非裔美国男性艾滋病毒/性病预防计划
  • 批准号:
    8307236
  • 财政年份:
    2010
  • 资助金额:
    $ 37.66万
  • 项目类别:
ENDOMETRIOSIS IN RHESUS MACAQUES
恒河猴子宫内膜异位症
  • 批准号:
    7958748
  • 财政年份:
    2009
  • 资助金额:
    $ 37.66万
  • 项目类别:
Liberia School-Based HIV/STD Prevention Program
利比里亚学校艾滋病毒/性病预防计划
  • 批准号:
    7495580
  • 财政年份:
    2008
  • 资助金额:
    $ 37.66万
  • 项目类别:
ENDOMETRIOSIS IN RHESUS MACAQUES
恒河猴子宫内膜异位症
  • 批准号:
    7716422
  • 财政年份:
    2008
  • 资助金额:
    $ 37.66万
  • 项目类别:
Liberia School-Based HIV/STD Prevention Program
利比里亚学校艾滋病毒/性病预防计划
  • 批准号:
    7591692
  • 财政年份:
    2008
  • 资助金额:
    $ 37.66万
  • 项目类别:
HIV/STD Prevention for High-Risk Youth in Liberia
利比里亚高危青少年的艾滋病毒/性病预防
  • 批准号:
    7429667
  • 财政年份:
    2006
  • 资助金额:
    $ 37.66万
  • 项目类别:
HIV/STD Prevention for High-Risk Youth in Liberia
利比里亚高危青少年的艾滋病毒/性病预防
  • 批准号:
    7653757
  • 财政年份:
    2006
  • 资助金额:
    $ 37.66万
  • 项目类别:
HIV/STD Prevention for High-Risk Youth in Liberia
利比里亚高危青少年的艾滋病毒/性病预防
  • 批准号:
    7284844
  • 财政年份:
    2006
  • 资助金额:
    $ 37.66万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 37.66万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 37.66万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 37.66万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 37.66万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 37.66万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 37.66万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 37.66万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 37.66万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 37.66万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 37.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了